Cargando…
Schistosome Vaccine Adjuvants in Preclinical and Clinical Research
There is currently no vaccine available for human use for any parasitic infections, including the helminth disease, schistosomiasis. Despite many researchers working towards this goal, one of the focuses has been on identifying new antigenic targets. The bar to achieve protective efficacy in humans...
Autores principales: | Stephenson, Rachel, You, Hong, McManus, Donald, Toth, Istvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494218/ https://www.ncbi.nlm.nih.gov/pubmed/26344751 http://dx.doi.org/10.3390/vaccines2030654 |
Ejemplares similares
-
Schistosome Vaccines for Domestic Animals
por: You, Hong, et al.
Publicado: (2018) -
Innovations and Advances in Schistosome Stem Cell Research
por: You, Hong, et al.
Publicado: (2021) -
Revisiting glucose uptake and metabolism in schistosomes: new molecular insights for improved schistosomiasis therapies
por: You, Hong, et al.
Publicado: (2014) -
Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths
por: You, Hong, et al.
Publicado: (2017) -
Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders
por: Mu, Yi, et al.
Publicado: (2021)